title: Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report.
abstract: TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.
authors.affiliation: Rheumatology Unit, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Colaci
authors.forename: Marco
authors.initials: M
authors.lastname: Sebastiani
authors.forename: Gilda
authors.initials: G
authors.lastname: Sandri
authors.forename: Marisa
authors.initials: M
authors.lastname: Meacci
authors.forename: Clodoveo
authors.initials: C
authors.lastname: Ferri